Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer vaccines in the clinic
Morgan E. Janes, Alexander P. Gottlieb, Kyong Soo Park, et al.
Bioengineering & Translational Medicine (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

A Cancer Nanovaccine for Co-Delivery of Peptide Neoantigens and Optimized Combinations of STING and TLR4 Agonists
Jessalyn J. Baljon, Alexander J. Kwiatkowski, Hayden M. Pagendarm, et al.
ACS Nano (2024) Vol. 18, Iss. 9, pp. 6845-6862
Open Access | Times Cited: 39
Transforming Medicine: Cutting-Edge Applications of Nanoscale Materials in Drug Delivery
Rumiana Koynova, Kevin J. Hughes, Magesh Ganesan, et al.
ACS Nano (2025)
Open Access | Times Cited: 4
Injecting hope: the potential of intratumoral immunotherapy for locally advanced and metastatic cancer
Markéta Skaličková, Katerina Hadrava Vanova, Ondřej Uher, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 3
Ice-pop making inspired photothermal ultra-swelling microneedles to facilitate loading and intradermal vaccination of tumor antigen
Zhiming Li, Xueyu Wen, Lü Shaojie, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 77-88
Closed Access | Times Cited: 2
Alternative Splicing: A Key Regulator in T cell Response and Cancer Immunotherapy
C.-C. Yong, Yexin Liang, Minmin Wang, et al.
Pharmacological Research (2025), pp. 107713-107713
Open Access | Times Cited: 1
Emerging Therapeutic Targets and Future Directions in Advanced Gastric Cancer: A Comprehensive Review
Margherita Ratti, Elena Orlandi, Ilaria Toscani, et al.
Cancers (2024) Vol. 16, Iss. 15, pp. 2692-2692
Open Access | Times Cited: 4
Bacterial and cancerous cell membrane fused liposome coordinates with PD-L1 inhibitor for cancer immunotherapy
Xianjin Luo, Chenglong Li, Zhaofei Guo, et al.
Nano Research (2024) Vol. 17, Iss. 9, pp. 8389-8401
Closed Access | Times Cited: 4
Short Peptides as Powerful Arsenal for Smart Fighting Cancer
Joanna Bojarska, Wojciech M. Wolf
Cancers (2024) Vol. 16, Iss. 19, pp. 3254-3254
Open Access | Times Cited: 4
Cancer vaccine designed from homologous ferritin-based fusion protein with enhanced DC-T cell crosstalk for durable adaptive immunity against tumors
Jun Wu, Jing Liang, Sichen Li, et al.
Bioactive Materials (2025) Vol. 46, pp. 516-530
Closed Access
Cancer Vaccines
Matjaž Zorko, Ülo Langel
Methods in pharmacology and toxicology (2025), pp. 213-229
Closed Access
Harnessing the immune system: Insights into cancer vaccines
S. Acharya, Subhasmita Bhal, Biswajit Das, et al.
Advances in immunology (2025)
Closed Access
Advances in cancer nanovaccines: a focus on colorectal cancer
Yalda Ghazizadeh, Hossein Salehi Shadkami, Fatemeh Madani, et al.
Nanomedicine (2025), pp. 1-13
Closed Access
Vaccine formulation design: challenges and opportunities
Saman Zafar, Ambreen Akhtar, Elshaimaa Sayed, et al.
RSC Pharmaceutics (2025)
Open Access
In Situ Cancer Vaccines: Redefining Immune Activation in the Tumor Microenvironment
Prabhanjan Giram, Kazi Md Mahabubur Rahman, Osama Aqel, et al.
ACS Biomaterials Science & Engineering (2025)
Closed Access
Cell therapies against brain tumors: Clinical development and emerging prospects
Tatsuya Fukuta, Suyog Shaha, Andrés da Silva‐Candal, et al.
Bioengineering & Translational Medicine (2025)
Open Access
Exosome-based cancer vaccine: a cell-free approach
Swarup Sonar, Asmit Das, Ketki Kalele, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Advances and challenges in cancer immunotherapy: Strategies for personalized treatment
Mahir Azmal, MA Monayem Miah, Fatema Sultana Prima, et al.
Seminars in Oncology (2025) Vol. 52, Iss. 3, pp. 152345-152345
Closed Access
Integrating antigen capturing nanoparticles and type 1 conventional dendritic cell therapy for in situ cancer immunization
Chih-Jia Chao, Zhang Endong, Dieu-Thuong Thi Trinh, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Nano‐ and Micro‐Platforms in Therapeutic Proteins Delivery for Cancer Therapy: Materials and Strategies
Huijie Han, Hélder A. Santos
Advanced Materials (2024)
Open Access | Times Cited: 3
Emergence of Advanced Immunotherapy: New Horizons for HPV-Negative Head and Neck Squamous Cell Carcinoma
Madhan Krishnan, Shyamaladevi Babu, Manish Kumar, et al.
Oral Oncology Reports (2024) Vol. 12, pp. 100670-100670
Open Access | Times Cited: 2
Advances and challenges in anti-cancer vaccines for multiple myeloma
Pegah Abdollahi, Hanne Marie Norseth, Fredrik Schjesvold
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Advancements in Nuclear Imaging Using radiolabeled Nanobody tracers to support Cancer Immunotherapy
Katty Zeven, Yoline Lauwers, Lynn De Mey, et al.
Immunotherapy Advances (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 2
Mesothelin- and nucleolin-specific T cells from combined short peptides effectively kill triple-negative breast cancer cells
Suyanee Thongchot, Krittaya Aksonnam, Jaturawitt Prasopsiri, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Emerging Cancer Immunotherapies: Cutting-Edge Advances and Innovations in Development
Monica Maccagno, Marta Tapparo, Gabriele Saccu, et al.
Medical Sciences (2024) Vol. 12, Iss. 3, pp. 43-43
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top